ASTRO provides a checklist to help facilitate new submissions and revisions.
ASTRO is pleased to partner with Editage to offer a 10% discount for authors seeking copy editing and translation services. Please use this Author Services link to receive the discount. These services are offered for the benefit of authors, and individuals who participate will remain anonymous. Copy editing and translation are provided by Editage.
International Journal of Radiation Oncology●Biology●Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
The Red Journal is highly selective in what it accepts for publication.
Manuscripts with the highest likelihood of acceptance include novel prospective pilot studies (phase 1 and 2); randomized phase 2 and 3 studies; secondary analyses from prospective studies; and health sciences research, especially research that covers cost effectiveness and comparative effectiveness, quality assurance/quality of care and meta-analyses/systematic reviews that may influence future directions.
Our lower priority manuscripts include studies with a large-sized population treated in a consistent manner (i.e., the study will be one of the largest series in the medical literature, potentially an instructional "classic"); retrospective, hypothesis-generating studies with truly novel findings and appropriate methodology quality and innovation of methods (i.e., the study introduces some new means of analysis not previously available or newly applied); manuscripts that provide new insights into the natural history of disease or patterns of failure; and manuscripts that cover a current, controversial area in which the impact of findings has the high potential to solicit a related high-profile editorial or counterpoint piece.
For more information about the scope of all three ASTRO journals, please see our scope document.
Questions? Email firstname.lastname@example.org.
Authors must register with the Red Journal’s electronic manuscript system. Those who have previously reviewed or submitted a manuscript for the IJROBP are already registered. Once the submission files are uploaded, the system automatically generates an electronic PDF proof used for reviewing.
The Red Journal requires a $75 fee for all full-length clinical investigations, scientific letters, and critical review submissions. The following articles are exempt from submission fees:
During the submission process, authors will be directed to the Submission Start site to complete payment by a credit card.
The Red Journal uses double blind peer review, which means that the identities of the authors are concealed from the reviewers, and vice versa.
Please make sure you blind any of the following information in your submission:
*This is somewhat subjective and depends on the phrasing of the sentence. For example, “In our previous study ” clearly identifies the cited work as belonging to the authors and requires that reference 8 be blinded while “Recent studies show ” would be permissible with the reference unblinded.
Blinded text should always be removed or replaced with filler text such as “XXXX,” “Blinded for Review,” or asterisks. Blacking out text with Microsoft Word is inadmissible as the text is still searchable and can be copied/pasted to reveal the information. When blinding references, please leave the in-text reference number unblinded, but replace the entire corresponding line in the references section except the number with “XXXX” or similar.
Reviewers see almost all documents submitted with the exception of the cover letter, title page, and disclosure forms. The online submission form title and abstract must be blinded in addition to the manuscript document, figures, tables and any supplementary material.
Please do not include acknowledgements, conflict of interest statements or funding statements in the blinded manuscript document.
For more information please refer to https://www.elsevier.com/reviewers/peer-review.